BACKGROUND: Prolonged retention of an antibiotic spacer is occasionally chosen during treatment of periprosthetic joint infections after total hip arthroplasty (THA) and total knee arthroplasty (TKA). The purpose of our study was to evaluate the outcome of extended spacer retention. METHODS: We reviewed 1106 cases of periprosthetic joint infection after THA (n = 308) and TKA (n = 798) and identified 17 (5.5%) retained hip and 34 (4.3%) retained knee spacers. Most patients (35 of 51, 69%) underwent spacer retention because they were medically unfit for further surgery. The remaining patients (16 of 51, 31%) had acceptable function and forewent further surgery. Competing risk analyses, with death as the competing risk, determined the cumulative incidence of reinfection and spacer revision. Radiographic analysis and clinical outcomes were analyzed. RESULTS: The 2-year cumulative incidence for reinfection was 7% for retained hip and 13% for retained knee spacers. The cumulative incidence for all-cause spacer revision was 28% at 4 years for hips and 21% at 2 years for knees. The most common complications were implant migration and femoral spacer subsidence in the hip cohort, and supracondylar femur fractures and spacer dislocations in the knee cohort. The cumulative incidence for radiographic signs of mechanical failure was 72% and 87% at late follow-up for the hip and knee groups, respectively. The latest Harris Hip Score and Knee Society Score were 62 and 63, respectively. CONCLUSION: Antibiotic spacer retention is a rare event in the course of planned 2-stage treatment of infected THA or TKA. Failure secondary to recurrent infection is uncommon; however, failure for mechanical reasons is frequent and clinical outcomes are relatively poor.
BACKGROUND: Prolonged retention of an antibiotic spacer is occasionally chosen during treatment of periprosthetic joint infections after total hip arthroplasty (THA) and total knee arthroplasty (TKA). The purpose of our study was to evaluate the outcome of extended spacer retention. METHODS: We reviewed 1106 cases of periprosthetic joint infection after THA (n = 308) and TKA (n = 798) and identified 17 (5.5%) retained hip and 34 (4.3%) retained knee spacers. Most patients (35 of 51, 69%) underwent spacer retention because they were medically unfit for further surgery. The remaining patients (16 of 51, 31%) had acceptable function and forewent further surgery. Competing risk analyses, with death as the competing risk, determined the cumulative incidence of reinfection and spacer revision. Radiographic analysis and clinical outcomes were analyzed. RESULTS: The 2-year cumulative incidence for reinfection was 7% for retained hip and 13% for retained knee spacers. The cumulative incidence for all-cause spacer revision was 28% at 4 years for hips and 21% at 2 years for knees. The most common complications were implant migration and femoral spacer subsidence in the hip cohort, and supracondylar femur fractures and spacer dislocations in the knee cohort. The cumulative incidence for radiographic signs of mechanical failure was 72% and 87% at late follow-up for the hip and knee groups, respectively. The latest Harris Hip Score and Knee Society Score were 62 and 63, respectively. CONCLUSION: Antibiotic spacer retention is a rare event in the course of planned 2-stage treatment of infected THA or TKA. Failure secondary to recurrent infection is uncommon; however, failure for mechanical reasons is frequent and clinical outcomes are relatively poor.
Authors: Jessica Hooper; Prerna Arora; Shanthi Kappagoda; James I Huddleston; Stuart B Goodman; Derek F Amanatullah Journal: Arthroplast Today Date: 2021-03-11
Authors: Jan Hubert; Frank Timo Beil; Tim Rolvien; Christian Ries; Stephan Frosch; Dominik Saul; Thelonius Hawellek Journal: Sci Rep Date: 2021-03-04 Impact factor: 4.379
Authors: Maxime Jaubert; Marie Le Baron; Christophe Jacquet; Antoine Couvreur; Maxime Fabre-Aubrespy; Xavier Flecher; Matthieu Ollivier; Jean-Noel Argenson Journal: Bone Jt Open Date: 2022-06
Authors: Alireza K Nazemi; Alexander Upfill-Brown; Armin Arshi; Troy Sekimura; Erik N Zeegen; Edward J McPherson; Alexandra I Stavrakis Journal: Arch Orthop Trauma Surg Date: 2021-02-24 Impact factor: 2.928
Authors: Lucas da Ponte Melo; Guilherme Augusto Losso; Guilherme Henrique Ricardo da Costa; José Ricardo Pécora; Marco Kawamura Demange; Camilo Partezani Helito Journal: Acta Ortop Bras Date: 2019 Sep-Oct Impact factor: 0.513